Latest Asx Listings News

Page 14 of 271
Eve Health Group (ASX:EVE) says it knows of no undisclosed information that would explain a sharp fall and surge in trading volume. The company suggested selling by a formerly associated shareholder may have contributed, without identifying the seller or quantifying the disposal.
Victor Sage
Victor Sage
26 Oct 2026
European Lithium has secured Supreme Court approval for its proposed share and option schemes with Critical Metals Corp., removing the central legal hurdle to the transaction. The deal is now expected to move from ASX trading to a NASDAQ-listed CRML structure in early November, subject to the court orders being lodged with ASIC.
Maxwell Dee
Maxwell Dee
26 Oct 2026
Queste Communications is seeking shareholder approval to leave the ASX, arguing that limited trading, concentrated ownership and listing costs no longer justify its quoted status. If approved and accepted by ASX, trading could end on 29 December 2026, leaving shareholders to sell privately after delisting.
Victor Sage
Victor Sage
26 Oct 2026
Orion Equities will ask shareholders to approve a voluntary ASX delisting, arguing that sparse trading, concentrated ownership and annual listing costs no longer justify its quoted status. The move would leave shareholders relying on private transactions to sell their shares if the delisting proceeds.
Claire Turing
Claire Turing
26 Oct 2026
GR Engineering Services delivered stronger FY26 earnings and lifted its dividend, but the scale of its new project pipeline is bringing a substantial working-capital requirement. The ASX-listed contractor is forecasting FY27 revenue of A$825 million to A$850 million after securing more than A$1 billion in contracts since April.
Victor Sage
Victor Sage
26 Oct 2026
Syrah Resources is set to receive a further US$15 million from the US International Development Finance Corporation before the end of October, providing working and sustaining capital for its Balama graphite operation. The funding comes with a temporary waiver of existing loan defaults, new warrants and no guarantee of further disbursements.
Victor Sage
Victor Sage
26 Oct 2026
GreenTech Metals has extended the tested Ayshia mineralised trend at Whundo by about 65 metres beyond its existing resource envelope, with drilling returning 4.76 metres at 7.13% copper plus zinc, gold and silver. The ASX-listed explorer enters the December quarter with more Whundo assays, a resource update and Munni Munni target testing still ahead.
Maxwell Dee
Maxwell Dee
26 Oct 2026
EMVision Medical Devices has taken its pivotal emu™ trial beyond 230 participants while preparing to add acute ischaemic stroke detection to the FDA validation program. The ASX-listed medtech ended September with $18.1 million in cash and $3.7 million in remaining grant funding.
Victor Sage
Victor Sage
26 Oct 2026
Pureprofile has started FY27 with record quarterly revenue of $18.3 million and EBITDA of $2.4 million, while Platform revenue more than doubled. The ASX-listed data and insights company maintained its revenue guidance and lifted its EBITDA margin outlook to 11% to 12%.
Victor Sage
Victor Sage
26 Oct 2026
Genetic Signatures has added a new AGM resolution seeking approval to issue up to 340.7 million shares and 129.7 million options under its proposed Microba merger. The all-scrip transaction remains non-binding and subject to further shareholder, court, regulatory and due diligence conditions.
Ada Torres
Ada Torres
23 Oct 2026
C29 Metals ended September with $219,000 in cash and estimated funding for just 0.59 quarters, while its proposed $2.4 million placement remains subject to shareholder approval. The explorer reported no on-site exploration during the quarter, as it moved to cut costs and rationalise its portfolio.
Maxwell Dee
Maxwell Dee
23 Oct 2026
Saluda Medical delivered 28% FY26 revenue growth and expanded its spinal cord stimulation opportunity with CAP24, but its annual report warns that additional capital may be needed within 12 months. The ASX-listed medical device company also begins FY27 under new CEO Michael Mathias.
Victor Sage
Victor Sage
23 Oct 2026

Browse the archive

Full archive